One-dimensional CsPbBr

Baowei Zhang, Kexin Chen, Zhengkun Xie, Kun Hu, Haiyun Dong, Yong Sheng Zhao, Liberato Manna, Siyu Lu

Abstract read

In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Baowei Zhang *College of Chemistry, Pingyuan Laboratory, Zhengzhou University, Zhengzhou, China.

Kexin Chen *College of Chemistry, Pingyuan Laboratory, Zhengzhou University, Zhengzhou, China.

Zhengkun XieCollege of Chemistry, Pingyuan Laboratory, Zhengzhou University, Zhengzhou, China.

Kun HuBeijing National Laboratory for Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China.

Haiyun DongBeijing National Laboratory for Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China.ORCID http://orcid.org/0000-0003-2650-8016

Yong Sheng ZhaoBeijing National Laboratory for Molecular Sciences, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China.ORCID http://orcid.org/0000-0002-4329-0103

Liberato MannaNanochemistry, Istituto Italiano di Tecnologia, Genova, Italy. Liberato.Manna@iit.it.ORCID http://orcid.org/0000-0003-4386-7985

Siyu LuCollege of Chemistry, Pingyuan Laboratory, Zhengzhou University, Zhengzhou, China. sylu2013@zzu.edu.cn.ORCID http://orcid.org/0000-0003-4538-7846

Funding

China Postdoctoral Science Foundation 2022TQ0290Ministry of Science and Technology of the People's Republic of China (Chinese Ministry of Science and Technology) DL2023026004LNational Science Foundation of China | Young Scientists Fund No. 22305224 and U24A2079Natural Science Foundation of Henan Province (Henan Province Natural Science Foundation) 242300421127

6 · The paper itself

Abstract

Nanocrystal superlattices typically occur in two- or three-dimensional configurations, constrained to the micrometer scale and with limited size tunability. Here, we report one-dimensional superlattices prepared by self-assembly of CsPbBr

Identifiers

PMID42177171

DOI10.1038/s41467-026-73513-2

PMCPMC13385850

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.